title: Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers.
abstract: Although hepatitis C virus (HCV) mainly affects hepatocytes, infection is widespread and involves immunologically privileged sites. Whether lymphoid cells represent further targets of early HCV infection, or whether other cells in the hematopoietic microenvironment may serve as a potential virus reservoir, is still unclear. We studied whether pluripotent hematopoietic CD34(+) cells support productive HCV infection and can be used to establish an in vitro infection system for HCV. Six patients were selected as part of a cohort of HCV chronic carriers who developed a neoplastic disease. Reverse transcriptase-polymerase chain reaction (RT-PCR) and branched DNA signal amplification assays were used to detect and quantitate HCV RNA in extracted nucleic acids from purified bone marrow and peripheral blood CD34(+) cells. Direct in situ RT-PCR, flow cytometry analysis, and immunocytochemistry were applied to demonstrate specific viral genomic sequences and structural and nonstructural virus-related proteins in intact cells. Results indicated that both positive and negative HCV RNA strands and viral proteins were present in CD34(+) cells from all HCV-positive patients and in none of the controls. Additional experiments showed that a complete viral cycle took place in CD34(+) cells in vitro. Spontaneous increases in viral titers indicated that virions were produced by infected hematopoietic progenitor cells. To further define the cellular tropism, we attempted to infect CD34(+) cells in vitro. We were unable to demonstrate viral uptake by cells. These findings suggest that HCV replication can occur in the early differentiation stages of hematopoietic progenitor cells, and that they may be an important source of virus production.
authors.affiliation: Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Sansonno
authors.forename: C
authors.initials: C
authors.lastname: Lotesoriere
authors.forename: V
authors.initials: V
authors.lastname: Cornacchiulo
authors.forename: M
authors.initials: M
authors.lastname: Fanelli
authors.forename: P
authors.initials: P
authors.lastname: Gatti
authors.forename: G
authors.initials: G
authors.lastname: Iodice
authors.forename: V
authors.initials: V
authors.lastname: Racanelli
authors.forename: F
authors.initials: F
authors.lastname: Dammacco
mesh_terms: D000368:Aged; D018952:Antigens, CD34 / Q000032:analysis; D002353:Carrier State / Q000473:pathology / Q000821:virology*; D015331:Cohort Studies; D005260:Female; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000473:pathology / Q000821:virology*; D016174:Hepacivirus / Q000302:isolation & purification* / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000473:pathology / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D012367:RNA, Viral / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014764:Viral Proteins / Q000032:analysis; D014776:Virus Cultivation; D014779:Virus Replication
chemical_list: D018952:Antigens, CD34; D012367:RNA, Viral; D014764:Viral Proteins